rs12983316

chr19-11003676-A-G

Variant summary

Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_Strong BP6_Moderate BA1

The NM_001387283.1(SMARCA4):c.2001+279A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.123 in 151,490 control chromosomes in the GnomAD database, including 1,438 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

• Frequency: Genomes: 𝑓 0.12 (1438 hom., cov: 32)
• Consequence: SMARCA4 NM_001387283.1 intron
• Clinical Significance: Benign criteria provided, single submitter B:1
• Conservation: PhyloP100: 0.468

Genes affected

SMARCA4 (HGNC:11100): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4) The protein encoded by this gene is a member of the SWI/SNF family of proteins and is similar to the brahma protein of Drosophila. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI, which is required for transcriptional activation of genes normally repressed by chromatin. In addition, this protein can bind BRCA1, as well as regulate the expression of the tumorigenic protein CD44. Mutations in this gene cause rhabdoid tumor predisposition syndrome type 2. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2012]

ACMG classification

Verdict is Benign. Variant got -14 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.9).
• BP6: Variant 19-11003676-A-G is Benign according to our data. Variant chr19-11003676-A-G is described in ClinVar as [Benign]. Clinvar id is 1248789.Status of the report is criteria_provided_single_submitter, 1 stars.
• BA1: GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.186 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	MANE	UniProt
SMARCA4	NM_001387283.1	c.2001+279A>G		intron_variant		ENST00000646693.2
SMARCA4	NM_003072.5	c.2001+279A>G		intron_variant		ENST00000344626.10

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	TSL	MANE	Appris	UniProt
SMARCA4	ENST00000344626.10	c.2001+279A>G		intron_variant		1	NM_003072.5	P4
SMARCA4	ENST00000646693.2	c.2001+279A>G		intron_variant			NM_001387283.1

Frequencies

GnomAD3 genomes AF: 0.123 AC: 18599 AN: 151414 Hom.: 1437 Cov.: 32

Gnomad AFR AF: 0.0305

Gnomad AMI AF: 0.0881

Gnomad AMR AF: 0.192

Gnomad ASJ AF: 0.118

Gnomad EAS AF: 0.00136

Gnomad SAS AF: 0.0865

Gnomad FIN AF: 0.212

Gnomad MID AF: 0.0641

Gnomad NFE AF: 0.163

Gnomad OTH AF: 0.119

We have no GnomAD4 exomes data on this position. Probably position not covered by the project.

GnomAD4 genome AF: 0.123 AC: 18595 AN: 151490 Hom.: 1438 Cov.: 32 AF XY: 0.126 AC XY: 9295 AN XY: 73962

Gnomad4 AFR AF: 0.0304

Gnomad4 AMR AF: 0.192

Gnomad4 ASJ AF: 0.118

Gnomad4 EAS AF: 0.00136

Gnomad4 SAS AF: 0.0876

Gnomad4 FIN AF: 0.212

Gnomad4 NFE AF: 0.163

Gnomad4 OTH AF: 0.118

Alfa AF: 0.148 Hom.: 1827

Bravo AF: 0.115

Asia WGS AF: 0.0400 AC: 139 AN: 3478

ClinVar

Significance: Benign

Submissions summary: Benign:1

Revision: criteria provided, single submitter

Submissions by phenotype

not provided Benign:1

Benign, criteria provided, single submitter

clinical testing

GeneDx

Jul 26, 2018

- -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.90
Cadd	Benign	3.7
Dann	Benign	0.70

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.010		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs12983316; hg19: chr19-11114352;